Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study. (2019)
Attributed to:
MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2018.07.028
PubMed Identifier: 30130616
Publication URI: http://europepmc.org/abstract/MED/30130616
Type: Journal Article/Review
Volume: 139
Parent Publication: The Journal of investigative dermatology
Issue: 1
ISSN: 0022-202X